Yangtianhe Pharmacy Co., Ltd. signed Share Transfer Agreement to acquire 7% stake in Guangdong Jiaying Pharmaceutical Co., Ltd (SZSE:002198) from Chen Shaobin for approximately CNY 360 million on July 9, 2024. A cash consideration of CNY 355.26 million will be paid by Yangtianhe Pharmacy Co., Ltd at a price of CNY 10 per share. As part of consideration, CNY 355.26 million is paid towards common equity of Guangdong Jiaying Pharmaceutical Co., Ltd.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6.69 CNY | +0.90% |
|
-12.20% | -8.10% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-8.10% | 464M | |
+13.97% | 4.95B | |
-32.08% | 3.6B | |
-1.63% | 3.03B | |
-24.62% | 2.66B | |
-9.82% | 2.34B | |
+38.87% | 1.85B | |
+38.84% | 1.45B | |
-15.47% | 1.41B | |
+40.95% | 1.38B |
- Stock Market
- Equities
- 002198 Stock
- News Guangdong Jiaying Pharmaceutical Co., Ltd
- Yangtianhe Pharmacy Co., Ltd. signed Share Transfer Agreement to acquire 7% stake in Guangdong Jiaying Pharmaceutical Co., Ltd from Chen Shaobin for approximately CNY 360 million.